FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039172568> ?p ?o ?g. }

• W3039172568 endingPage "4824" @default.
• W3039172568 startingPage "4811" @default.
• W3039172568 abstract "Magnetic resonance imaging (MRI) contrast agents are pharmaceuticals that enable a better visualization of internal body structures. In this study, we present the synthesis, MRI signal enhancement capabilities, in vitro as well as in vivo cytotoxicity results of gold-coated iron oxide nanoparticles (Fe3O4@AuNPs) as potential contrast agents.Fe3O4@AuNPs were obtained by synthesizing iron oxide nanoparticles and gradually coating them with gold. The obtained Fe3O4@AuNPs were characterized by spectroscopies, transmission electron microscopy (TEM) and energy dispersive X-ray diffraction. The effect of the nanoparticles on the MRI signal was tested using a 7T Bruker PharmaScan system. Cytotoxicity tests were made in vitro on Fe3O4@AuNP-treated retinal pigment epithelium cells by WST-1 tests and in vivo by following histopathological changes in rats after injection of Fe3O4@AuNPs.Stable Fe3O4@AuNPs were successfully prepared following a simple and fast protocol (<1h worktime) and identified using TEM. The cytotoxicity tests on cells have shown biocompatibility of Fe3O4@AuNPs at small concentrations of Fe (<1.95×10-8 mg/cell). Whereas, at higher Fe concentrations (eg 7.5×10-8 mg/cell), cell viability decreased to 80.88±5.03%, showing a mild cytotoxic effect. MRI tests on rats showed an optimal Fe3O4@AuNPs concentration of 6mg/100g body weight to obtain high-quality images. The histopathological studies revealed significant transient inflammatory responses in the time range from 2 hours to 14 days after injection and focal cellular alterations in several organs, with the lung being the most affected organ. These results were confirmed by hyperspectral microscopic imaging of the same, but unstained tissues. In most organs, the inflammatory responses and sublethal cellular damage appeared to be transitory, except for the kidneys, where the glomerular damage indicated progression towards glomerular sclerosis.The obtained stable, gold covered, iron oxide nanoparticles with reduced cytotoxicity, gave a negative T2 signal in the MRI, which makes them suitable for candidates as contrast agent in small animal MRI applications." @default.
• W3039172568 created "2020-07-10" @default.
• W3039172568 creator A5032085172 @default.
• W3039172568 creator A5032200480 @default.
• W3039172568 creator A5038259032 @default.
• W3039172568 creator A5041851095 @default.
• W3039172568 creator A5043011163 @default.
• W3039172568 creator A5056088259 @default.
• W3039172568 creator A5059299420 @default.
• W3039172568 creator A5067348729 @default.
• W3039172568 creator A5083722160 @default.
• W3039172568 creator A5088368756 @default.
• W3039172568 date "2020-07-01" @default.
• W3039172568 modified "2023-10-15" @default.
• W3039172568 title "<p>Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies</p>" @default.
• W3039172568 cites W1824959035 @default.
• W3039172568 cites W1928602914 @default.
• W3039172568 cites W1978648897 @default.
• W3039172568 cites W1982826997 @default.
• W3039172568 cites W2009304781 @default.
• W3039172568 cites W2013306455 @default.
• W3039172568 cites W2027876233 @default.
• W3039172568 cites W2029170057 @default.
• W3039172568 cites W2032186406 @default.
• W3039172568 cites W2032816988 @default.
• W3039172568 cites W2035246484 @default.
• W3039172568 cites W2041321390 @default.
• W3039172568 cites W2047988521 @default.
• W3039172568 cites W2051450866 @default.
• W3039172568 cites W2054980591 @default.
• W3039172568 cites W2066280082 @default.
• W3039172568 cites W2077228161 @default.
• W3039172568 cites W2084944797 @default.
• W3039172568 cites W2091570843 @default.
• W3039172568 cites W2092062478 @default.
• W3039172568 cites W2099710563 @default.
• W3039172568 cites W2108968243 @default.
• W3039172568 cites W2126346850 @default.
• W3039172568 cites W2131009328 @default.
• W3039172568 cites W2132005699 @default.
• W3039172568 cites W2149952617 @default.
• W3039172568 cites W2155961553 @default.
• W3039172568 cites W2156899880 @default.
• W3039172568 cites W2161297906 @default.
• W3039172568 cites W2169215251 @default.
• W3039172568 cites W2169262628 @default.
• W3039172568 cites W2271740119 @default.
• W3039172568 cites W2313555423 @default.
• W3039172568 cites W2360949387 @default.
• W3039172568 cites W2405919788 @default.
• W3039172568 cites W2484908553 @default.
• W3039172568 cites W2515696338 @default.
• W3039172568 cites W2582413035 @default.
• W3039172568 cites W2602753471 @default.
• W3039172568 cites W2612811041 @default.
• W3039172568 cites W2623723222 @default.
• W3039172568 cites W2738840595 @default.
• W3039172568 cites W2759055943 @default.
• W3039172568 cites W2762019095 @default.
• W3039172568 cites W2780839798 @default.
• W3039172568 cites W2783521109 @default.
• W3039172568 cites W2795472833 @default.
• W3039172568 cites W2805521463 @default.
• W3039172568 cites W2882983394 @default.
• W3039172568 cites W2889894770 @default.
• W3039172568 cites W2896682297 @default.
• W3039172568 cites W2912780423 @default.
• W3039172568 cites W2957160586 @default.
• W3039172568 cites W2982216357 @default.
• W3039172568 cites W4242599454 @default.
• W3039172568 doi "https://doi.org/10.2147/ijn.s253184" @default.
• W3039172568 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7355080" @default.
• W3039172568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32753867" @default.
• W3039172568 hasPublicationYear "2020" @default.
• W3039172568 type Work @default.
• W3039172568 sameAs 3039172568 @default.
• W3039172568 citedByCount "16" @default.
• W3039172568 countsByYear W30391725682020 @default.
• W3039172568 countsByYear W30391725682021 @default.
• W3039172568 countsByYear W30391725682022 @default.
• W3039172568 countsByYear W30391725682023 @default.
• W3039172568 crossrefType "journal-article" @default.
• W3039172568 hasAuthorship W3039172568A5032085172 @default.
• W3039172568 hasAuthorship W3039172568A5032200480 @default.
• W3039172568 hasAuthorship W3039172568A5038259032 @default.
• W3039172568 hasAuthorship W3039172568A5041851095 @default.
• W3039172568 hasAuthorship W3039172568A5043011163 @default.
• W3039172568 hasAuthorship W3039172568A5056088259 @default.
• W3039172568 hasAuthorship W3039172568A5059299420 @default.
• W3039172568 hasAuthorship W3039172568A5067348729 @default.
• W3039172568 hasAuthorship W3039172568A5083722160 @default.
• W3039172568 hasAuthorship W3039172568A5088368756 @default.
• W3039172568 hasBestOaLocation W30391725681 @default.
• W3039172568 hasConcept C104819515 @default.
• W3039172568 hasConcept C109316439 @default.
• W3039172568 hasConcept C12554922 @default.
• W3039172568 hasConcept C126838900 @default.
• W3039172568 hasConcept C136229726 @default.

• next